学术日程
学术会议安排
日期 |
上午 |
下午 |
6月21日 | 报到 | 报到 |
6月22日 | 大会特邀报告 | 大会特邀报告 |
6月23日 | 分会场报告 | 大会特邀报告 |
大会特邀报告人
报告人 | 报告题目 | 单位 |
Torsten Tonn |
Development of a natural killer cell line (NK-92) for the immunotherapy of cancer |
Transfusion Medicine Technical university Dresden, Germany |
Evren Alici |
Strategies to restore and retarget NK cell function in cancer |
Department of Medicine Huddinge, Karolinska Institutet, Sweden |
Jianhua Yu |
Arming Natural Killer Cells with Chimeric Antigen Receptors for Cancer Treatment |
James Cancer Hospital of The Ohio State University, USA |
Daniel A Vallera |
Improving the Bispecific Antibody Platform to Recruit and Expand NK Cells as an Alternative to T cell Cancer Therapy |
Radiation Oncology, University of Minnesota Masonic Cancer Center,USA |
Yangxin Fu |
Antibody targeting tumor cells to trigger anti-tumor immunity |
UT Southwestern Medical Center,Texas, USA |
Weiping Zou |
Metabolic control of immune cell subsets in the tumor microenvironment |
University of Michigan School of Medicine, USA |
José A. Guevara-Patino |
TBD |
Oncology Institute, Loyola University, USA |
Gianpietro Dotti |
TBD |
University of North Carolina, USA |
Sacha Gnjatic |
Lessons from NY-ESO-1 spontaneous immunity for cancer vaccines and tumor immunotherapy |
Tisch Cancer Institute Hematology/Oncology, Immunology Icahn School of Medicine at Mount Sinai, New York, USA |
田志刚 | TBD |
University of Science Technology of China, China |
黄波 |
Why we get cancer and how we do not get cancer? |
Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, China |
韩卫东 | TBD |
Chinese PLA General Hospital, China |
郑利民 |
PD-L1 and Myeloid cells in human tumor microenvironments |
School of Life Sciences, Tumor Biotherapy, Cancer Center, Sun Yat-sen University, China |
储以微 |
Tumor Immunotherapy: From Bench to Bedside |
Biotherapy Research Center of Fudan University, China |
秦晓峰 |
A novel mechanism of acquired resistance to anti-PD-1/PD-L1 therapy by CD38-mediated immune checkpoint regulation |
Center for Systems Medicine, Chinese Academy of Medical Sciences; Suzhou Institute of Systems Medicine, China |
张建 |
Studies on STAT3-targeting strategies in HCC therapy |
School of Pharmaceutical Science, Shandong University, China |
张彩 |
Reactivation of oncofetal gene SALL4 by hepatitis B virus opposes miR-200c in PD-L1-induced T cell exhaustion |
School of Pharmaceutical Sciences, Shandong University, China |
俞德超 |
TBD |
Sichuan University, China |
王盛典 |
TBD |
Institute of Biophysics; The Chinese Academy of Sciences; China |
崔正荣 |
Vaccine adjuvant discovery by modifying the physicochemical properties of insoluble aluminum salts |
College of Basic Sciences, Inner Mongolia Medical University, China |